Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease

Keyphrases

• Zebrafish 100%
• Motor Dysfunction 100%
• Branched-chain 100%
• Maple Syrup Urine Disease 100%
• Motor Model 100%
• Transacylase 100%
• Locomotor 75%
• Branched-chain Amino Acid Metabolism 75%
• Spinal Cord 50%
• Dystonia 50%
• Motility 25%
• Glutamate 25%
• Neurotransmitters 25%
• Intellectual Disability 25%
• Candidate Gene Study 25%
• Peripheral Nerve Recording 25%
• Neurological Injury 25%
• Point mutation 25%
• Positional Cloning 25%
• Amino Acid Content 25%
• Neurological Death 25%
• Human Disease Models 25%
• Zebrafish mutant 25%
• Nervous System Development 25%
• Human mutations 25%
• Axial muscles 25%
• Positional Candidate 25%
• Larval Zebrafish 25%
• Neural Network Function 25%
• Mitochondrial Enzyme Complex 25%
• Locomotive Behavior 25%
• DBT Gene 25%

Neuroscience

• N-Acetyltransferase 100%
• Maple Syrup Urine Disease 100%
• Stereotypic Movement Disorder 100%
• Branched-Chain Amino Acid 75%
• Metabolic Pathway 75%
• Dystonia 50%
• Behavior (Neuroscience) 50%
• Peripheral Nerve 25%
• Neural Network 25%
• Glutamic Acid 25%
• Amino Acid 25%
• Neurotransmitter 25%
• Point Mutation 25%
• Mitochondrial Enzyme 25%
• Nose 25%
• Neurogenesis 25%

Biochemistry, Genetics and Molecular Biology

• Zebra Fish 100%
• Dihydrolipoamide 100%
• N-Acetyltransferase 100%
• Amino Acid Metabolism 60%
• Nervous System Development 20%
• Candidate Gene 20%
• Amino Acids 20%
• Neurotransmitter 20%
• Molecular Cloning 20%
• Gene Analysis 20%
• Enzyme 20%
• Point Mutation 20%
• DBT (Gene) 20%
• Glutamic Acid 20%